Risankizumab for Ulcerative Colitis
2024 · JAMA · 98 citations
https://doi.org/10.1001/jama.2024.12414
K
Kamal Patel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
482
Citations
10
h-index
10
i10-index
Kamal Patel is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Helicobacter pylori-related gastroenterology studies. The author has an h-index of 10, co-authored 57 publications.
ORCID: 0000-0002-8114-2283Papers by this author
worksGuselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
2024 · The Lancet · 67 citations
https://doi.org/10.1016/s0140-6736(24)01927-5
Self-rated health supersedes patient satisfaction with service quality as a predictor of survival in prostate cancer
2015 · Health and Quality of Life Outcomes · 28 citations
https://doi.org/10.1186/s12955-015-0334-1
Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis
2025 · Clinical Gastroenterology and Hepatology · 3 citations
https://doi.org/10.1016/j.cgh.2025.07.025
Efficacy of Transforaminal Nerve Root Block in Lumbar Radiculopathy
2025 · Cureus · 1 citations
https://doi.org/10.7759/cureus.89754
Surgical and Functional Outcomes of Distal Femur Fractures Operated With Distal Femur Locking Compression Plate Versus Intramedullary Supracondylar Nail
2025 · Cureus · 0 citations
https://doi.org/10.7759/cureus.83062
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat